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Lipopolysaccharide (LPS) is a potent endotoxin, which produces “sickness behaviours” including loss of weight, loss of interest in food and
decreased exploration. LPS has also been shown in some studies to cause deficits in various learning and memory abilities, while in others these
LPS-induced learning impairments have been attributed to performance-related deficits rather than learning deficits per se. Here, we use the
novelty-preference paradigm, a task that minimises performance-related factors such as motivation, in an attempt to extract and examine the
effects of LPS on spatial learning. In addition, some studies have indicated that the anti-inflammatory cytokine Interleukin-10 (IL-10) can alleviate
some of the symptoms induced by LPS. Here, we also examine the effect of IL-10 on feeding, motor and learning behaviours. We demonstrate that
a single injection of LPS does produce a lack of interest in food and weight loss; LPS, however, does not impair habituation in the novelty-
preference paradigm. Furthermore, co-injection of IL-10 with LPS does not attenuate the LPS-induced effects of weight loss and lack of food
intake. Interestingly, a single injection of IL-10 produces abnormal patterns of exploration, a general increase in activity and abnormal patterns of
habituation.
© 2006 Elsevier Inc. All rights reserved.Keywords: Lipopolysaccharide; Interleukin-10; Cytokine; Exploration; Habituation; Balb/c1. Introduction
Exposure to the endotoxin Lipopolysaccharide (LPS), a non-
infectious component of Gram-negative bacterial cell walls,
results in a similar pyrogenic response produced by pathogens
[1]. This adaptive response, often referred to as “sickness
behaviours” produces several symptoms including lethargy,
reduced activity and exploration, decreased social interaction,
fever, appetite suppression, activation of the hypothalamic–
pituitary–adrenal (HPA) axis, as well as decrements in cognitive
functioning such as in learning and memory [2,3]. LPS
stimulates the synthesis and release of pro-inflammatory
cytokines by attaching to Toll-like receptors (TLRs), in
particular TLR4, which mediate the expression of genes⁎ Corresponding author. Tel.: +353 1 7086182; fax: +353 1 7084767.
E-mail address: DEIRDRE.R.HARVEY@nuim.ie (D. Harvey).
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doi:10.1016/j.physbeh.2006.03.002involved in the inflammatory response [4] leading to the
sickness experienced.
The adverse effect of LPS on learning and memory has
been demonstrated across a range of behavioural paradigms.
Research has found that LPS-treated mice take longer and
make more errors when performing a spatial learning task [5].
LPS has also been shown to impair context-dependent fear-
conditioning [6], the Morris Water Maze task [7], the novelty-
preference paradigm [8], and the passive avoidance learning
task [9]. There is however, a growing body of evidence
suggesting that the LPS effects observed on learning in many
of these behavioural paradigms may actually be due to the
performance-related impairments rather than learning deficits
per se. Such performance-related impairments may be
attributed to deficits in attention, motivation, anxiety and/or
other factors, which in turn, may or otherwise contribute to the
learning deficits seen with LPS [2]. Research examining the
effects of LPS on spatial memory in the Water Maze, for
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but no effect on the learning itself [10]. Other studies involving
intracerebroventricular infusion of IL-1β also demonstrate no
effect on spatial memory when tested in the Water Maze task,
while infusions of the IL-1 receptor antagonist (IL-1Ra)
resulted in memory impairment [11], suggesting that some
cytokines, such as IL-1β, may in fact enhance memory
processes. In addition, other studies examining the effects of
LPS and IL-1 on a delayed-match to sample task and the Y-
maze task showed motivational effects rather than learning
impairments [12], again adding credence to the suggestion that
LPS and cytokines, like IL-1, may result in performance-
related rather than cognitive deficits.
Interleukin-10 (IL-10) has been used to reduce synthesis and
release of several pro-inflammatory cytokines like IL-1, TNFα
and IL-6 [13–15]. IL-10 plays a central role in striking a balance
between responding to and eliminating an infection while
minimising injury to host tissue [16]. IL-10 pre-treatment
suppresses inflammation through interference with monocyte
functioning and macrophage activation, reducing cytokine
synthesis, giving resistance to the fever responses induced by
LPS [16]. The inhibitory effects of IL-10 on IL-1 and TNF
production are fundamental to its anti-inflammatory activities,
as these cytokines intensify the response by initiating secondary
mediators [16]. IL-10 has also been shown to attenuate the
behavioural effects of LPS [1], reversing the effects upon social
exploration and interaction, mobility and depressed body
weight while modulating the vascular effects of LPS [17,18].
Further research has found that giving IL-10 prior to LPS
administration increases exploratory locomotor activity, as
measured by the frequency of rearing and ambulations made,
in an open field arena [19]. It has been demonstrated that IL-10
also reduces sleeping patterns, in particular non-rapid eye
movement sleep [20].
One simple task used to examine spatial learning and
memory is the novelty-preference paradigm. In this task
animals are required to passively explore an environment
filled with objects. When placed in an unfamiliar arena
rodents display exploratory activity towards most aspects of
this new environment, particularly towards the objects present
[21]. It is believed that an animal's spatial knowledge of its
surroundings depend on such exploration. When the animal is
placed in the same environment a second time there is a
decrease in the locomotor and exploratory activities (habitu-
ation), which will continue to occur as long as the
environment remains constant [22,23]. Several of the
previously outlined paradigms (such as the Morris Water
Maze) make use of the working memory and long-term
memory, engaging multiple cognitive processes. However, the
novelty-preference paradigm involves a lighter cognitive load
as it does not actively teach animals any clear relationship
between the consequences of their behaviour and the presence
of the objects [24]. Furthermore, unlike many paradigms
(such as the Water Maze) which require strong motivational
and perhaps anxiety-driven behaviour (escaping from rela-
tively cold water), the novelty-preference task does not rely
on such factors and therefore may be useful in attempting toseparate LPS-induced learning deficits from any performance-
related impairments.
The current study examines the effect of LPS on learning in
the novelty-preference paradigm and also examines the role
played by IL-10 in alleviating fever responses induced by LPS.
Specifically, we hypothesize that many “sickness behaviours”
induced by LPS such as lack of appetite and weight loss will be
attenuated by a co-injection of IL-10 and LPS. In addition, we
further hypothesize that the reduced exploration and learning
consequences of LPS, in the novelty-preference paradigm, will
be reversed by co-administration with IL-10.
2. Methods
Male Balb/c mice (N=32, Jackson Laboratory, Bar Harbour,
Maine, USA) aged 6–8 weeks and weighing approximately
30 g were used as subjects. Mice were housed 8/large cage in a
temperature-controlled room (21±1 °C), maintained on a
12 h:12 h light/dark cycle (lights on at 07:00 hr). Animals
had free access to food and water. Animals were randomly
assigned to one of four groups (N=8/group): Saline control
group: Saline (0.9%). LPS group: LPS at a dose of 300 μg/kg
(Escherichia coli, serotype 0111:B4; Sigma Chemical, Dorset,
UK). LPS was dissolved in sterile phosphate buffered saline
(PBS, 0.9%). LPS and IL-10 group: IL-10 at a dose of 130 μg/kg
and LPS at a dose of 300 μg/kg in 0.3 ml PBS (0.9%) co-
administered. IL-10 only group: IL-10 at a dose of 130 μg/kg
(BD Bioscience, Oxford, UK) in 0.3 ml PBS (0.9%). Each
group was injected (i.p.) once 6 h prior to habituation training
with their respective solution. A 6 h period allowed sufficient
time for the administered dosages to take effect [1,2,5]. The
dosage amounts were selected upon these previous findings and
the animal bodyweight measurements [2]. Following injections,
mice were weighed and returned to an individual cage. The food
and water supplied in each cage were recorded. After 6 h food,
water, and bodyweight were reweighed.
Following this animals were brought to the testing
laboratory. Each animal was brought into the experimental
room in individual cages. Each mouse was then individually
tested in a separate, cordoned off experimental arena, out of
view of the other animals. Once finished experimenting, each
animal was then returned to a common group cage. Each animal
received one trial in an open field where they were allowed to
explore the empty arena for 1 min. This consisted of a small box
(40×30×10 cm). The experimenter was not in the experimental
area during this phase. EthoVision (Noldus Information
Technology, Wageningen, The Netherlands), a computerised
digital tracking system measured the distance travelled (cm),
velocity (cm/sec), and the total duration (%) spent in predefined
sections of the arena, (the outer edge and inner section), that
were equal in area during this trial. Upon the completion of this
trial, subjects were transferred to the habituation arena and
received three trials.
The experimental apparatus used for the habituation testing
consisted of a white circular arena (diameter 40 cm, height
15 cm) resting on a platform 70 cm off the ground. A black
curtain surrounded the entire arena, with a white rectangular
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south east of the arena and a second light bulb directly above the
circular arena provided the light. Four objects were placed in the
centre of the arena in a square formation, approximately 10 cm
apart. The objects consisted of a circular black jar lid (diameter
5 cm, height 0.5 cm); a small rock (approximately 4.2 cm
diameter); a glass cylinder (diameter 5 cm, height 7 cm); and a
yellow matchbox (diameter 3.5 cm, height 1 cm).
A trial consisted of the mouse being placed into the arena,
allowed to explore the environment for one minute, whilst the
experimenter, located at the west side of the arena, recorded the
nose contacts made with each object. Subjects were removed
from the arena after the allotted time and placed in an open-
topped box for an inter-trial interval of 15 s. All data were
analysed using the standard analysis of variance (ANOVA)
procedures followed by post-hoc comparisons (Tukey HSD).
3. Results
The amount of food consumed by each group was measured
6 h post-injection. A significant difference was found between
the groups' overall food consumption (F(3,28) = 33.04,
p<0.001). Post-hoc tests (Tukey HSD, p<0.05) indicated that
the LPS group ate significantly less food than the Saline control
group and the IL-10 only group over the 6 h period.
Furthermore, the LPS and IL-10 group also consumed
significantly less food overall compared to the Saline control
group and the IL-10 only group (see Fig. 1a).Food consumed (g)
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Fig. 1. (a) The mean amount of food consumed and (b) the mean weight gain/
loss at 6 h post-injection. ⁎p<0.05, ⁎⁎ p<0.01, ⁎⁎⁎ p<0.001 levels of
significance.All mice were weighed twice, once immediately post-
injection and once 6 h post-injection. Overall significant
differences were found between the groups (F(3,28)=15.68,
p<0.001). Post-hoc comparisons revealed that the LPS group
lost significantly more weight compared to the Saline control
group and the IL-10 only group during this time (see Fig. 1b).
The LPS and IL-10 group also lost significantly more weight
than the Saline controls six hours post-injection. No further
differences were found.
Prior to the habituation task all mice were allowed one
minute in the open field. Fig. 2a shows the mean distance
travelled by all groups during this trial. A significant difference
was found between the groups (F(3,28)=2.896, p=0.05). Post-
hoc comparisons revealed that the LPS only group travelled a
significantly shorter distance than the IL-10 only group. No
further differences were found. Analysis of the mean velocity
per day for each group again showed an overall difference
between the groups' scores (F(3,28)=4.51, p<0.05). Subse-
quent post-hoc comparisons indicated that the LPS only group
was significantly slower than both the Saline control group and
the IL-10 only group, illustrating the LPS group's diminished
rate of activity (see Fig. 2b).
The arena was divided into two equal areas, an outer edge
and an inner section (see inset Fig. 2c), to examine the
exploration patterns of each experimental group. The total
duration (%) spent in both of these predefined sections was
then assessed using a 4×2 repeated-measures ANOVA.
Although there was no main effect for the experimental
group, a significant effect for the arena section was revealed
(F(1,14)=21.04, p<0.001). An interaction (Group X Section)
effect was also demonstrated (F(3,42)=13.079, p<0.001).
Subsequent t-tests revealed that the LPS and IL-10 group and
the IL-10 only group spent significantly more time in the outer
edge of the arena when compared to the inner section (t(7)
=2.761, p<0.05; t(7)=9.237, p<0.001). A further one-way
ANOVA revealed a significant difference between the four
groups' total duration (%) time spent in the outer edge (F
(3,28)=4.644, p<0.01). Post-hoc comparisons showed that the
IL-10 only group spent significantly more time in this section
of the arena compared to the Saline control group and the LPS
only group (see Fig. 2c). No further differences were noted
between the groups.
Learning among the four experimental groups was assessed
using a 3×4 repeated measures ANOVA. A main effect for the
group (F(3,28)=3.576, p<0.05) was revealed. Post-hoc tests
(Tukey HSD) showed that the LPS group made significantly
less nose contacts overall when compared to the IL-10 only
group. An overall main effect for the trial was also found (F
(2,56)=45.08, p<0.001). Each individual group showed
significant decreases in the nose contacts made during the
habituation trials. The Saline control group showed a significant
decrease in the nose contacts made (F(2,23)=8.313, p<0.01)
during the task with significantly less made in trial 3 than in trial
1. The LPS and IL-10 group also showed habituation (F(2,23)
=13.226, p<0.001) with significantly less nose contacts made
on trials 2 and 3 than on trial 1. Interestingly, the LPS only
group also demonstrated habituation (F(2,23)=5.296, p<0.05)
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Fig. 2. (a) The mean distance travelled (cm) and (b) the mean velocity (cm/sec) and (c) the total duration (%) spent in the inner and outer sections of the arena during the
open field task (arena sections outlined and a typical IL-10 only group trial inset). ⁎p<0.05, ⁎⁎p<0.01, ⁎⁎⁎ p<0.001 levels of significance.
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Fig. 3. Line chart demonstrating the mean number of nose contacts made with
each of the four objects for each group during the three habituation trials of the
novelty preference task. ⁎p<0.05 level of significance.
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3 compared to trial 1. The IL-10 only group showed an overall
significant difference in nose contacts made with the objects
throughout the habituation task (F(2,23)=5.133, p<0.05).
Significantly less nose contacts were made with the objects on
trial 2 compared to trial 1. However, no differences were noted
between trial 1 and trial 3 due to the irregular increase in nose
contacts shown between trial 2 and 3. A Group X trial
interaction effect (F(6,56)=2.172, p=0.05) was also found. A
significant difference between the four groups on trial 1 (F
(3,28)=4.978, p<0.01) and trial 3 (F(3,28)=4.524, p<0.05)
was found. No differences were observed between the groups
on trial 2. Post-hoc comparisons indicated that the IL-10 only
group made significantly more nose contacts with the objects
compared to both the Saline control group (p<0.05) and the
LPS only group (p<0.01) on trial 1. On trial 3 the IL-10 only
group made significantly more nose contacts than the LPS
846 D. Harvey et al. / Physiology & Behavior 87 (2006) 842–847group (p<0.05) and the LPS and IL-10 group (p<0.05) (see
Fig. 3).
4. Discussion
We demonstrated that LPS does have the predicted effects on
some measures of “sickness behaviours”, as outlined by the
previous research [3,25]. We showed, for example, that the LPS
only group consumed significantly less food and water and lost
significantly more bodyweight when compared to the Saline
control group. Injections of LPS only also reduced the overall
velocity in the open field when compared to the Saline control
group, in line with the previous research [2,10]. Injections of
LPS did not however impair habituation in the novelty-
preference paradigm, as we had hypothesized in the introduc-
tion. Instead, the LPS only group habituated readily to the task,
reducing their interest in the objects significantly by the third
trial. In addition, no significant differences in the mean number
of nose contacts made with the objects were noted between the
LPS and the Saline control group on any of the three trials. This
result would suggest to us, in common with many of the
previously reported studies [2,10,12], that LPS may not have a
strong and clear adverse effect on learning. As suggested by
Sparkman et al. [2,10] studies that attribute learning impairments
to LPS may in fact be due to the other performance-related
impairments, such as motivational or anxiety-related factors. By
using the novelty-preference paradigm we had hoped to
eliminate some of these motivational issues and we have
demonstrated, at least in our set-up, that learning does not seem
to be impaired in the LPS only group. However, other
methodological possibilities that may explain the lack of
learning impairments seen with the LPS group cannot be ruled
out. The 6 h timeframe used in this experiment, although used by
the previous studies [1] may have been too long and the
behavioural effects of LPSmay have already reached its peak. In
addition, the one-minute trial duration may not have been
sufficient to reduce the potential stress of being placed into a
novel environment.
It is documented that IL-10 is a potent anti-inflammatory
cytokine modulating and regulating the effects of LPS [1,17]
through the antagonism of IL-12 [18]. We hypothesize that the
co-injection of IL-10 and LPS (i.e. IL-10 and LPS group) would
attenuate some of the “behavioural sickness” effects imposed by
LPS. However, our results did not confirm this. The LPS and
IL-10 group (similar to the LPS only group) ate significantly
less and lost significantly more weight when compared to the
Saline control group. In addition, the habituation patterns
observed with the LPS and IL-10 group did not differ
significantly from either the LPS only or the Saline groups.
Previous research has shown that IL-10 can attenuate the effects
of LPS in certain behavioural conditions, this effect, for
example, has been observed in social exploration [1].
Furthermore it is noted that in the current experiment IL-10
and LPS were co-administered, whereas in the previous
outlined studies [1,16] pre-treatment was used. This may
account for some of the differences in results when directly
comparing studies. Future research should take this intoconsideration. Consequently, we suggest that IL-10 at the
concentration administered in the current experiment does not
attenuate the effects of LPS.
An unexpected finding to the current study showed that
exclusive administration of IL-10 produced a general increase
in behavioural activity and abnormal behavioural and learning
patterns compared to the other experimental groups. It was
observed that the IL-10 only group had higher distance and
velocity scores, spent a significantly shorter duration of time
in the inner section of the arena, and made more overall nose
contacts during the habituation compared to the other groups.
The IL-10 only group spent a significantly longer time
(approximately 80%) in the outer edge of the arena compared
to the Saline controls and the LPS only group, who only spent
approximately 50% in each of these sections, highlighting the
IL-10 only groups' abnormal behaviour. It was observed that
this group would run around the side of the arena
demonstrating a thigmotactic-like behaviour [26] (see Fig. 2c
inset). One particular interpretation of this behaviour is that
IL-10 may be affecting emotionality or anxiety levels of the
animals. It has been suggested that thigmotaxis is thought to
belong to the category of phylogenetically prepared fear
reactions [27]. Indeed, thigmotactic or wall-seeking behaviour
has been observed in several species [28–30] and it is reported
to be the likely result of small rodents trying to avoid open,
unknown and potentially dangerous areas [29,30]. To
emphasise the interpretation of thigmotaxis as a sign of
anxiety, Treit [27] strongly recommends that this wall-seeking
behaviour be used when testing anxiolytic drugs. We would
also suggest that the injection of IL-10 had the effect of
increasing anxiety in our animals, which manifested in them
spending more time at the periphery of the open field rather
than any other area. Our results also show that this group was
particularly active during habituation trials, making more nose
contacts with the objects compared to the other groups
(especially trials 1 and 3). Overall they displayed an irregular
pattern of habituation with a decrease in the number of nose
contacts made between trial 1 and trial 2 as expected. This is
then followed by a renewal of exploration, increasing nose
contacts between trial 2 and trial 3 (revealed by no significant
differences between trial 1 and trial 3). This is again
inconsistent with normal habituation patterns, when the
number of nose contacts made by trial three should be much
reduced. Again, this abnormal pattern may be a direct result
from increased anxiety induced by IL-10.
In summary, LPS-treated animals did show certain sickness-
type behaviours. They showed a decrease in food consumption,
loss in bodyweight and a reduction in velocity in the open field.
This group did not however, show any learning impairments
thereby adding to the ongoing debate of the exact role of LPS in
higher-order cognition. Interestingly, exclusive administration
of IL-10 produced abnormal patterns of exploration, by
spending much of their time at the outer edge of the arena. In
addition, this group were generally more active and made
significantly more nose contacts with the objects in the novelty-
preference paradigm, as well as an abnormal pattern of
habituation to this task.
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